Literature DB >> 11803489

Evaluation of the ELOVL4 gene in patients with age-related macular degeneration.

R Ayyagari1, K Zhang, A Hutchinson, Z Yu, A Swaroop, L E Kakuk, J M Seddon, P S Bernstein, R A Lewis, J Tammur, Z Yang, Y Li, H Zhang, B M Yashar, J Liu, K Petrukhin, P A Sieving, R Allikmets.   

Abstract

Stargardt-like macular degeneration (STGD(3)) and autosomal dominant macular degeneration (adMD) share phenotypic characters with atrophic age-related macular degeneration (AMD). Mutations in a photoreceptor cell-specific factor involved in the elongation of very long chain fatty acids (ELOVL(4)) were shown to be associated with STGD(3), adMD, and pattern dystrophy. We screened 778 patients with AMD and 551 age-matched controls to define the role of sequence variants in the ELOVL(4) gene in age-related macular degeneration. We detected three sequence variants in the non-coding region and eight variants in the coding region. No statistically significant association was observed between sequence variants in the ELOVL(4) gene and susceptibility to AMD. However, for the detection of modest effects of multiple alleles in a complex disease, the analysis of larger cohorts of patients may be required.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11803489     DOI: 10.1076/opge.22.4.233.2219

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  15 in total

Review 1.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

Review 2.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

Review 3.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

4.  A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions.

Authors:  Johanna M Seddon; Susan L Santangelo; Kathryn Book; Sandy Chong; Jennifer Cote
Journal:  Am J Hum Genet       Date:  2003-08-22       Impact factor: 11.025

Review 5.  The molecular genetic basis of age-related macular degeneration: an overview.

Authors:  Saritha Katta; Inderjeet Kaur; Subhabrata Chakrabarti
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 6.  Genetics of age-related macular degeneration: current concepts, future directions.

Authors:  Margaret M Deangelis; Alexandra C Silveira; Elizabeth A Carr; Ivana K Kim
Journal:  Semin Ophthalmol       Date:  2011-05       Impact factor: 1.975

7.  Serum levels of lipid metabolites in age-related macular degeneration.

Authors:  Tivadar Orban; William M Johnson; Zhiqian Dong; Tadao Maeda; Akiko Maeda; Tsutomu Sakai; Hiroshi Tsuneoka; John J Mieyal; Krzysztof Palczewski
Journal:  FASEB J       Date:  2015-07-17       Impact factor: 5.191

Review 8.  Genetics and genetic testing for age-related macular degeneration.

Authors:  A Warwick; A Lotery
Journal:  Eye (Lond)       Date:  2017-11-10       Impact factor: 3.775

Review 9.  [Y402H polymorphism in complement factor H and age-related macula degeneration (AMD)].

Authors:  H P N Scholl; B H F Weber; M M Nöthen; T Wienker; F G Holz
Journal:  Ophthalmologe       Date:  2005-11       Impact factor: 1.059

10.  Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach.

Authors:  Alexandra C Silveira; Margaux A Morrison; Fei Ji; Haiyan Xu; James B Reinecke; Scott M Adams; Trevor M Arneberg; Maria Janssian; Joo-Eun Lee; Yang Yuan; Debra A Schaumberg; Maria G Kotoula; Evangeline E Tsironi; Aristoteles N Tsiloulis; Dimitrios Z Chatzoulis; Joan W Miller; Ivana K Kim; Gregory S Hageman; Lindsay A Farrer; Neena B Haider; Margaret M DeAngelis
Journal:  Vision Res       Date:  2009-09-26       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.